vers la météo de la validation par utilisateur

Ingenuity307

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 53 - PMID ?

In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                                                                                                           +-----------------MOD_ATT:N-N-----------------+                              
                                                          +-------------OBJ:V-N-------------+              |      +--------------MOD_ATT:N-N-------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 1 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          |                                                +-----------------MOD_ATT:N-N-----------------+                              
                                                          +-------------OBJ:V-N-------------+              |      +--------------MOD_ATT:N-N-------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 2 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 3 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 4 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 5 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 6 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                 +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 7 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 8 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                 +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 9 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 10 
                                                                                                           +-----------------MOD_ATT:N-N-----------------+                              
                                                          +-------------OBJ:V-N-------------+              |      +--------------MOD_ATT:N-N-------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 11 
                                                          +-------------OBJ:V-N-------------+              +-----------------MOD_ATT:N-N-----------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      +--------------MOD_ATT:N-N-------------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 12 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          |                                                +-----------------MOD_ATT:N-N-----------------+                              
                                                          +-------------OBJ:V-N-------------+              |      +--------------MOD_ATT:N-N-------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 13 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +-------------OBJ:V-N-------------+              +-----------------MOD_ATT:N-N-----------------+                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              |      +--------------MOD_ATT:N-N-------------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,time)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 14 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 15 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 16 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 17 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 18 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 19 
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 20 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 21 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     +---------------------------COMP:N-N(of)--------------------------+   
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
COMP:N-N(of) (dependent,mRNA)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 22 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                                            +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 23 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                 +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 24 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 25 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 26 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                 +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 27 
                                                          +-------------OBJ:V-N-------------+                                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                                            +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                                 +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 28 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |           +--------MOD_ATT:N-N-------+-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      |        +MOD_ATT:N-+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |        |          |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 29 
                                                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                              
                                                          +----------------------COMP:V-N(in)---------------------+                                      |                              
                                                          +-------------OBJ:V-N-------------+                     |                                      |                              
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                     |                                      +-------COMP:N-N(of)-------+   
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                     |           +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ+   
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              +MOD_AT+           |      +---MOD_ATT:N-ADJ---+           |       +MOD_AT+   
       |      |     |    |        |         |       |     |       |       |        |        |              |      |           |      |                   |           |       |      |   
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a time dependent and dose dependent manner ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,dependent)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (dependent,time)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)